City

Boston (3)

Brewer (1)

Columbus (1)

Duarte (1)

Houston (1)

Miami (1)

Pittsfield (1)

Portland (1)

Condition

Richter Syndrome (3)

Chronic Lymphocytic Leukemia (2)

Diffuse Large B-Cell Lymphoma (1)

Follicular Lymphoma (1)

Indolent Non-Hodgkin Lymphoma (1)

Lymphoplasmacytic Lymphoma (1)

Marginal Zone Lymphoma (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (2)

City of Hope Medical Center (1)

Collaborator

Genentech, Inc. (1)

National Cancer Institute (NCI) (1)

Secura Bio, Inc. (1)

Intervention

venetoclax (2)

copanlisib (1)

da-epoch-r (1)

duvelisib (1)

nivolumab (1)

r-chop (1)

Study Documents

Intervention Type

drug (3)

biological (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

richter syndrome

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Lymphocytic Leukemia, Richter Syndrome Trial in United States (Duvelisib, Venetoclax)

Recruiting

Chronic Lymphocytic Leukemia
Richter Syndrome

Miami, Florida
+6 more

Jan 6, 2023

Richter Syndrome Trial in United States (Venetoclax, DA-EPOCH-R, R-CHOP)

Recruiting

Richter Syndrome

Venetoclax
+2 more

Boston, Massachusetts
+2 more

Jan 6, 2023

Chronic Lymphocytic Leukemia, DLBCL, Follicular Lymphoma Trial in Duarte, Boston, Portland (Copanlisib, Nivolumab)

Recruiting

Chronic Lymphocytic Leukemia
+6 more

Copanlisib
Nivolumab

Duarte, California
+2 more

Mar 9, 2022